LAL Ph+. Futuro senza chemioterapia sistemica e trapianto?

Prof. Robin Foà
LAL Ph+. Futuro senza chemioterapia sistemica e trapianto?
Foà R, et al. Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults. GIMEMA Investigators. N Engl J Med. 2020 Oct 22;383(17):1613-1623.
Foà R, Chiaretti S. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. N Engl J Med. 2022 Jun 23;386(25):2399-2411